glp 1 news GLP-1 receptor agonists show promise in treating substance use disorders GLP-1 Pipeline Update: May 2026

Economic, Accessibility, and Health Equity Considerations The economic considerations surrounding the use of Ozempic and similar GLP-1 receptor agonists (such as Wegovy which uses the same active ingredient), encompass numerous aspects of the economy and healthcare system

As a representative example of this advanced in vitro approach, in 2021 Peter Ertls group established a synovium-on-chip platform that leverages patient-derived FLS

This unique combination forms a potent antioxidant and regenerative compound that possesses a remarkable ability to stimulate various cellular processes essential for maintaining healthy, youthful-looking skin

Immunity Glutathione helps your immune systems stay healthy and ready to fight infections